Over its decades-long operating history, Nu Skin Enterprises has faced multiple class-action lawsuits, shareholder complaints, and civil regulatory actions regarding its multi-level marketing distribution model, recruiting practices, and commercial marketing claims. Historical legal scrutiny from agencies like the Federal Trade Commission involved allegations that the enterprise or its independent distributors exaggerated potential distributor earnings and made unverified health or therapeutic claims about specific supplement lines. While the company has historically resolved past legal actions through financial settlements without admitting wrongdoing, these disputes have drawn continuous public and regulatory debate surrounding direct-selling practices.